Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national
national blog main
novartis
3
×
bristol-myers squibb
cancer
cancer immunotherapy
samit hirawat
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
approval
apremilast
base editing
bio
biogen
biome
blueprint medicineas
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
briefing docs
car-t
celgene
cervical cancer
clinical study
clinical trial
commissioner
crispr
crispr therapeutics
cybersecurity
democrats
detection
detroit blog main
detroit top stories
What
diversity
3
×
acquisition
anniversary
approaches
bn
bristol
celgene
chief
clinical
company’s
corporation
hirawat
medical
myers
myers’s
officer
pipeline
progress
scrip
spoke
squibb
trial
year
allogene
bio
cancer
crispr
hot
immunotherapy
investors
ipo
juno
million
nearly
new
remains
roundup
shares
snapped
therapeutics
Language
unset
Current search:
novartis
×
diversity
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
